Industry News
Pharmaceutical Industry News

Roche will invest $750 million to…
Roche will invest $750 million to double the size of its Genentech unit's manufacturing facility in Hillsboro, Oregon. The new outlay will support the construction of a fill-finish plant that will produce drug-delivery devices, such
Less than a year after the FDA…
Less than a year after the FDA turned down the resubmitted application for the company’s leukemia prospect Dasynoc, Xspray Pharma has again hit a wall at the U.S. regulator.
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
China’s investigator-initiated…
China's investigator-initiated trials, once praised for their speediness, have been drawn into scrutiny for a lack of transparency. AstraZeneca and Daiichi Sankyo's Enhertu earned a win in a phase 3 non-small cell lung cancer trial.
Aurinia Pharmaceuticals has struck…
Aurinia Pharmaceuticals has struck a patent infringement settlement with Teva Pharmaceuticals, which should help stave off Teva's proposed generic for its lupus drug, Lupkynis (voclosporin), in the United States until December of 2036. With the
B. Braun Medical—a maker of IV…
B. Braun Medical—a maker of IV solutions for hospitals, among other products—has initiated a recall in the United States and Canada spurred by particulate contamination.
What Is Treatment-Resistant Depression?
If multiple antidepressants haven’t helped, there are other avenues to explore.
Healthcare comms and…
Healthcare comms and commercialization agency Lucid Group has hired Eric Muller as its new chief executive officer.
Boehringer Ingelheim has continued…
Boehringer Ingelheim has continued its rise up patient groups’ ranking of rare disease companies, adding to last year’s gains to cement its status toward the top of the leaderboards. But the German drugmaker failed to
If at first you don’t succeed in…
If at first you don’t succeed in gene therapy, then try, try again, is the lesson Ultragenyx likely took home this week, pocketing its first FDA nod in the class a little over a year
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
Hundreds of thousands of patients…
Hundreds of thousands of patients with type 2 diabetes could eventually make the switch to a weekly insulin injection and reduce their annual injections by 85% after NICE, the U.K.’s drug cost watchdog, gave Lilly's
Just eight months after it…
Just eight months after it introduced its Wegovy pill, Novo Nordisk is testing the GLP-1 in smaller doses in the phase 3 OASIS 5 study.
HCP marketers have spent years…
HCP marketers have spent years perfecting whom to reach. The harder question, and the one that decides whether a message lands, is when.
For the first time, SK…
For the first time, SK Biopharmaceuticals has reached a settlement with a generics manufacturer that has applied for FDA approval of a copycat version of its epilepsy treatment Xcopri, local news outlets report. SK’s deal
The summer of the high-potency…
The summer of the high-potency active pharmaceutical ingredient expansion continues, as yet another manufacturing specialist makes inroads to boost capacity for sensitive, in-demand drug ingredients.
Jazz’s bispecific antibody…
Jazz’s bispecific antibody Ziihera has gained an FDA approval for first-line HER2-positive stomach cancer, unlocking another market as the company builds toward a $2 billion-plus peak sales target.
After receiving a checkered…
After receiving a checkered regulatory scorecard in 2024, Aurobindo’s sterile injectables and oncology unit is back in the FDA’s crosshairs.
When clients start directing more…
When clients start directing more and agencies start thinking less, it may feel like the relationship has run its course. But starting over isn’t the only way to get fresh thinking.
Genetix Biotherapeutics is teaming…
Genetix Biotherapeutics is teaming up with the NFL Alumni Association for a U.S. awareness and education drive centered on sickle cell disease.


